2020 Q1 Form 10-Q Financial Statement
#000143774920010599 Filed on May 13, 2020
Income Statement
Concept | 2020 Q1 | 2019 Q1 | 2018 Q4 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.020M | $810.0K | $380.0K |
YoY Change | 25.93% | 55.77% | -50.0% |
% of Gross Profit | |||
Research & Development | $1.349M | $2.607M | $1.740M |
YoY Change | -48.25% | 229.58% | 167.69% |
% of Gross Profit | |||
Depreciation & Amortization | $6.000K | $6.000K | $10.00K |
YoY Change | 0.0% | 50.0% | |
% of Gross Profit | |||
Operating Expenses | $1.349M | $3.421M | $2.120M |
YoY Change | -60.57% | 161.94% | 50.35% |
Operating Profit | -$2.404M | -$3.421M | |
YoY Change | -29.73% | 161.94% | |
Interest Expense | $0.00 | -$10.00K | |
YoY Change | -100.0% | -106.67% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$12.00K | -$178.0K | $180.0K |
YoY Change | -93.26% | -127.09% | -28.0% |
Pretax Income | -$2.416M | -$3.243M | -$1.960M |
YoY Change | -25.5% | 399.69% | 94.06% |
Income Tax | $9.000K | $9.000K | $10.00K |
% Of Pretax Income | |||
Net Earnings | -$2.425M | -$3.252M | -$1.960M |
YoY Change | -25.43% | 400.31% | 100.0% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$185.4K | -$271.7K | -$219.2K |
COMMON SHARES | |||
Basic Shares Outstanding | 14.14M | 11.96M | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2020 Q1 | 2019 Q1 | 2018 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $12.60M | $13.76M | $16.82M |
YoY Change | -8.42% | 104.75% | 1145.93% |
Cash & Equivalents | $3.300M | $2.759M | $16.82M |
Short-Term Investments | $9.300M | $11.00M | |
Other Short-Term Assets | $540.0K | $300.0K | $370.0K |
YoY Change | 80.0% | 500.0% | 516.67% |
Inventory | |||
Prepaid Expenses | $369.0K | ||
Receivables | $985.0K | $929.0K | $780.0K |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $14.17M | $14.94M | $17.97M |
YoY Change | -5.21% | 97.41% | 1102.95% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $60.00K | $90.00K | $96.00K |
YoY Change | -33.33% | 28.57% | 159.46% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $270.0K | $270.0K | |
YoY Change | 0.0% | 0.0% | |
Total Long-Term Assets | $200.0K | $550.0K | $367.0K |
YoY Change | -63.64% | 66.67% | 19.16% |
TOTAL ASSETS | |||
Total Short-Term Assets | $14.17M | $14.94M | $17.97M |
Total Long-Term Assets | $200.0K | $550.0K | $367.0K |
Total Assets | $14.37M | $15.49M | $18.34M |
YoY Change | -7.29% | 96.13% | 917.7% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $444.0K | $685.0K | $483.0K |
YoY Change | -35.18% | 7.03% | -47.5% |
Accrued Expenses | $435.0K | $686.0K | $808.0K |
YoY Change | -36.59% | 67.32% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $10.00K | $10.00K | $10.00K |
YoY Change | 0.0% | ||
Total Short-Term Liabilities | $935.0K | $1.425M | $1.296M |
YoY Change | -34.39% | 28.38% | 29.21% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $10.00K | $20.00K | $20.00K |
YoY Change | -50.0% | ||
Other Long-Term Liabilities | $100.0K | $150.0K | |
YoY Change | -33.33% | -92.72% | |
Total Long-Term Liabilities | $107.0K | $163.0K | $18.00K |
YoY Change | -34.36% | -92.09% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $935.0K | $1.425M | $1.296M |
Total Long-Term Liabilities | $107.0K | $163.0K | $18.00K |
Total Liabilities | $1.042M | $1.588M | $1.314M |
YoY Change | -34.38% | -49.91% | 31.01% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$59.04M | -$49.22M | -$45.97M |
YoY Change | 19.96% | 14.25% | |
Common Stock | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $13.32M | $13.91M | $17.03M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $14.37M | $15.49M | $18.34M |
YoY Change | -7.29% | 96.13% | 917.7% |
Cashflow Statement
Concept | 2020 Q1 | 2019 Q1 | 2018 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.425M | -$3.252M | -$1.960M |
YoY Change | -25.43% | 400.31% | 100.0% |
Depreciation, Depletion And Amortization | $6.000K | $6.000K | $10.00K |
YoY Change | 0.0% | 50.0% | |
Cash From Operating Activities | -$2.978M | -$3.134M | -$1.900M |
YoY Change | -4.98% | 235.19% | 95.88% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $2.000K | $10.00K | |
YoY Change | -200.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$5.300M | -$10.93M | |
YoY Change | -51.51% | ||
Cash From Investing Activities | -$5.301M | -$10.93M | $10.00K |
YoY Change | -51.49% | 34050.0% | -200.0% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $8.500M | $0.00 | |
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 7.696M | -2.000K | 14.82M |
YoY Change | -384900.0% | -100.03% | 856.13% |
NET CHANGE | |||
Cash From Operating Activities | -2.978M | -3.134M | -1.900M |
Cash From Investing Activities | -5.301M | -10.93M | 10.00K |
Cash From Financing Activities | 7.696M | -2.000K | 14.82M |
Net Change In Cash | -583.0K | -14.06M | 12.93M |
YoY Change | -95.85% | -362.54% | 2168.42% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.978M | -$3.134M | -$1.900M |
Capital Expenditures | $2.000K | $10.00K | |
Free Cash Flow | -$2.980M | -$3.134M | -$1.910M |
YoY Change | -4.91% | 224.1% | 98.96% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q1 | dmac |
Accrued Clinical Study Costs Current
AccruedClinicalStudyCostsCurrent
|
295000 | |
CY2019Q4 | dmac |
Accrued Clinical Study Costs Current
AccruedClinicalStudyCostsCurrent
|
433000 | |
CY2020Q1 | dmac |
Accrued Research And Professional Fees Current
AccruedResearchAndProfessionalFeesCurrent
|
49000 | |
CY2019Q4 | dmac |
Accrued Research And Professional Fees Current
AccruedResearchAndProfessionalFeesCurrent
|
172000 | |
CY2020Q1 | dmac |
Accrued Taxes And Other Liabilities Current
AccruedTaxesAndOtherLiabilitiesCurrent
|
18000 | |
CY2019Q4 | dmac |
Accrued Taxes And Other Liabilities Current
AccruedTaxesAndOtherLiabilitiesCurrent
|
52000 | |
CY2020Q1 | dmac |
Income From Governmental Assistance
IncomeFromGovernmentalAssistance
|
115000 | |
CY2019Q1 | dmac |
Income From Governmental Assistance
IncomeFromGovernmentalAssistance
|
174000 | |
CY2020Q1 | dmac |
Noncash Lease Expense
NoncashLeaseExpense
|
13000 | |
CY2019Q1 | dmac |
Noncash Lease Expense
NoncashLeaseExpense
|
12000 | |
CY2020Q1 | dmac |
Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
|
7700000 | |
CY2020Q1 | dmac |
Research And Development Incentive Receivable
ResearchAndDevelopmentIncentiveReceivable
|
908000 | |
CY2019Q4 | dmac |
Research And Development Incentive Receivable
ResearchAndDevelopmentIncentiveReceivable
|
793000 | |
CY2020Q1 | dmac |
Working Capital
WorkingCapital
|
13200000 | |
CY2020Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
435000 | |
CY2019Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1076000 | |
CY2020Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
444000 | |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
182000 | |
CY2020Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
985000 | |
CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
823000 | |
CY2020Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
435000 | |
CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1076000 | |
CY2020Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
49000 | |
CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
43000 | |
CY2020Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
42000 | |
CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2000 | |
CY2020Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
72323000 | |
CY2019Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
64232000 | |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
393000 | |
CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
130000 | |
CY2020Q1 | us-gaap |
Assets
Assets
|
14365000 | |
CY2019Q4 | us-gaap |
Assets
Assets
|
9053000 | |
CY2020Q1 | us-gaap |
Assets Current
AssetsCurrent
|
14165000 | |
CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
8836000 | |
CY2020Q1 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
200000 | |
CY2019Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
217000 | |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3883000 | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16823000 | |
CY2020Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3300000 | |
CY2019Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2759000 | |
CY2020Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-583000 | |
CY2019Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-14064000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
3300000 | |
CY2020Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
2821192 | |
CY2020Q1 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
0 | |
CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-3243000 | |
CY2019Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
0 | |
CY2020Q1 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
CY2019 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
CY2020Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14139074 | |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
12006874 | |
CY2020Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14139074 | |
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
12006874 | |
CY2020Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
||
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
||
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2385000 | |
CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3249000 | |
CY2020Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of credit risk</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains its cash balances primarily with <div style="display: inline; font-style: italic; font: inherit;">two</div> financial institutions. These balances generally exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses in such accounts and believes it is <div style="display: inline; font-style: italic; font: inherit;">not</div> exposed to any significant credit risk in cash and cash equivalents. The Company believes that the credit risk related to marketable securities is limited due to the adherence to an investment policy focused on the preservation of principal.</div></div></div></div></div></div></div></div> | |
CY2020Q1 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
195000 | |
CY2019Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
88000 | |
CY2020Q1 | us-gaap |
Depreciation
Depreciation
|
6000 | |
CY2019Q1 | us-gaap |
Depreciation
Depreciation
|
6000 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.19 | |
CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.27 | |
CY2020Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
73000 | |
CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
419000 | |
CY2020Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
6000 | |
CY2019Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
6000 | |
CY2020Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
11000 | |
CY2019Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
13000 | |
CY2020Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
2000 | |
CY2019Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
2000 | |
CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1023000 | |
CY2019Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
814000 | |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2416000 | |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
9000 | |
CY2019Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
9000 | |
CY2020Q1 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
38000 | |
CY2019Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
13000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
262000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
201000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
162000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
150000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-654000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-127000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
107000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
||
CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
290000 | |
CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-72000 | |
CY2020Q1 | us-gaap |
Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
|
14000 | |
CY2019Q1 | us-gaap |
Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
|
26000 | |
CY2020Q1 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.09 | |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
163000 | |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
46000 | |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
68000 | |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
49000 | |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
17000 | |
CY2020Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14365000 | |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
9053000 | |
CY2020Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
935000 | |
CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1318000 | |
CY2020Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
107000 | |
CY2019Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
118000 | |
CY2020Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
9300000 | |
CY2020Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
9348000 | |
CY2019Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
3995000 | |
CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3421000 | |
CY2020Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
16000 | |
CY2020Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
146000 | |
CY2020Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
50000 | |
CY2019Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-178000 | |
CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2404000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7696000 | |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5301000 | |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10928000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2978000 | |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3134000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2425000 | |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3252000 | |
CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
12000 | |
CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
54000 | |
CY2020Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
96000 | |
CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
105000 | |
CY2020Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
140000 | |
CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
153000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
40000 | |
CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
3000 | |
CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-127000 | |
CY2019Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
4000 | |
CY2020Q1 | us-gaap |
Other Receivables
OtherReceivables
|
39000 | |
CY2019Q4 | us-gaap |
Other Receivables
OtherReceivables
|
17000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
8799000 | |
CY2019Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
10928000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2000 | |
CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
||
CY2020Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
337000 | |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
47000 | |
CY2020Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
8500000 | |
CY2020Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
7682000 | |
CY2019Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
||
CY2020Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
3500000 | |
CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
||
CY2020Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
16000 | |
CY2019Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
||
CY2020Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
109000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
107000 | |
CY2020Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
60000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
64000 | |
CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1381000 | |
CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2607000 | |
CY2020Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-59042000 | |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-56617000 | |
CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
393000 | |
CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
130000 | |
CY2020Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
677566 | |
CY2020Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
1181309 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P7Y109D | |
CY2020Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
5.21 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P8Y | |
CY2020Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
4 | |
CY2020Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
393000 | |
CY2019Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
130000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
2125000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
7682000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
16000 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13323000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7617000 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17025000 | |
CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13906000 | |
CY2020Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
13000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
13107725 | |
CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
11956874 |